James Bennett of Liquibase walks through a live demo of targeted rollback, undoing one bad database change without a full restore or risky fix forward.

Spread the love“`html If you’re a developer spending any significant amount of time wrangling data, you’ve likely felt the ...

DORA enforcement is live in 2026. See what Article 9's ICT change management mandate means for database teams, and how to close the compliance gap.

AI video generators help you turn your prompts into believable videos, complete with audio. We've tested all the top services to help you choose the one that does the best job with the fewest tweaks.

Kualitee, an AI-powered test management platform built by quality engineering firm Kualitatem, announced the launch of Hootie Copilot on June 8, 2026, a new AI feature that generates automation ...

Threat actors in Latin America have begun to use AI agents to facilitate their entire attack chains, from assisting with initial access to generating penetration tools on the fly — and organizations ...

Director Destin Daniel Cretton, stars Tom Holland and Zendaya, and crew members offer an annotated script from the Sony/Marvel release.

According to @pictoryai on X, Pictory’s AI script generator converts a simple prompt into structured, ready‑to‑edit video scripts within seconds, accelerating the workflow from concept to content ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...